Monographie - Omeprazole sodium - Stabilis 4.0

Dernière mise à jour :
19/11/2024

Inhibiteur de la pompe à proton

Omeprazole sodium

Solution buvable

injectable

Stabilité des préparations

Stabilité en mélange

Facteur influençant la stabilité

Compatibilités

Bibliographie

pdf

Structure chimique

Solution buvable

Bibliographie

Solution buvable

Bibliographie : Omeprazole sodium

	Type	Source
2402	Revue	Burnett JE, Balkin ER. Stability and viscosity of a flavored omeprazole oral suspension for pediatric use Am J Health-Syst Pharm 2006 ; 63: 2240-2247.
2430	Revue	Quercia RA, Fan C, Liu X, Chow MS. Stability of omeprazole in an extemporaneously prepared oral liquid Am J Health-Syst Pharm 1997 ; 54: 1833-1836.
2546	Revue	DiGiacinto JL, Olsen KM, BergmanKL, Hoie EB. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes. Ann Pharmacotherapy 2000 ;34:600-605.
2886	Revue	Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding. Int J Pharm Compound 2009 ; 13, 3: 250-253.
2980	Revue	Johnson CE, Cober MP, Ludwig JL. Stability of partial doses of omeprazole-sodium bicarbonate oral suspension. Ann Pharmacotherapy 2007 ; 41: 1954-1961.
3302	Revue	Whaley P A, Voudrie M A, Sorenson B. Stability of Omeprazole in SyrSpend SF Alka (Reconstituted). Int J Pharm Compound 2012 ; 16, 2 : 164-166.
3913	Revue	Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O. Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. EJHP 2018 ;25,3:150-156.
4360	Revue	Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli. Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients. Hosp Pharm 2019
4388	Revue	Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment. Int J Pharm Compound 2020 ;24,2:140-147
4683	Revue	Low M, Singh S, Venkataya B, Pearson J, Ibrahim M, Jarouche M, Khoo C, Rowe J, Li CG. Stability of omeprazole in a commercial calcium carbonate based oral suspension at 2, 5 and 10 mg/mL stored under refrigeration (4°C) for 70 days J Pharm Pract and Res 2022 2022; 52, 34-41
4766	Revue	Spennacchio A, Assunta Lopedota A, Maria la Forgia F, Fontana S, Denora N, Lopalco A. Stability of omeprazole extemporaneous oral solution in Chopin Base. Int J Pharm Compound 2023 ;27,3:250-255

Mentions Légales